Welcome to the Daily Picks! Where Uptick staff looks for new companies to feature, giving readers the opportunity to find new possibilities for their investment portfolios.
TPIV: TapImmune, Inc.
TapImmune,Inc. (TPIV), a clinical-stage immunology-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, announced today plans to initiate a Phase 2 trial of its cancer vaccine, TPIV 200, a multi-epitope anti-folate receptor vaccine (FRα), in combination with Astra Zeneca (NYSE:AZN) durvalumab (MEDI4736), an anti-PD-L1 antibody, in patients with platinum-resistant ovarian cancer. The study will commence in the second quarter of 2016 at Memorial Sloan Kettering Cancer Center in New York and will be led by Jason Konner, M.D. as Principal Investigator.
The two Companies will share clinical costs, while TapImmune will supply TPIV 200 and MedImmune will supply Durvalumab (MED14736) for the trials. TapImmune recently obtained Orphan Drug Designation for TPIV 200 in ovarian cancer from the U.S. Food and Drug Administration.
GRNH: Greengro Technologies, Inc.
Greengro Technologies, Inc. (OTC PINK: GRNH), a world class provider of ecofriendly green technologies, announced today that it has acquired growcameras.com, a revolutionary way to monitor crop health. The Grow Camera is a self-contained, WiFi enabled, five megapixel NDVI camera and temp/humidity sensor. It can be used with most modern DVR equipment that support networked cameras while also featuring monitoring capabilities through Android, iOS, or Windows devices using the mobile application. The Grow Camera NDVI technology is traditionally used in space imaging and weather satellites, and can be used to quantify vegetation health and provide an early indicator to problems in the grow room.
As part of the growcamera.com acquisition, Greengro Technologies, Inc. (OTC PINK: GRNH) has also acquired technology to integrate temperature, humidity, CO2, pH, TDS, DO, and light sensors with a database for M&C (Monitor and Control) capability which will be integrated into the company’s existing horticultural offerings of modular gro rooms and light dep greenhouses.
Uptick encourages investors to do their own due diligence in determining investment strategies that work for them. Uptick’s opinion is based upon individual company and market factors. Invest at your own risk.